PPARgamma-PGC-1alpha activity is determinant of alcohol related breast cancer

Cancer Letters

Volumn 315, Issue 1, 2012, Pages 59-68

  Petersen, Rasmus Koefoed ^a   Larsen, Signe Benzon ^a,b,c   Jensen, Ditte Marie ^c,d   Christensen, Jane ^c   Olsen, Anja ^c   Loft, Steffen ^a   Nellemann, Christine ^e   Overvad, Kim ^f   Kristiansen, Karsten ^a   Tjønneland, Anne ^c   Vogel, Ulla ^b,d,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d ROSKILDE UNIVERSITY   (Denmark)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

Author keywords

Alcohol; Breast cancer; Polymorphism; Population based; PPARgamma

Indexed keywords

ALANINE; ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROLINE;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

AGED; ALCOHOL DRINKING; BREAST NEOPLASMS; DENMARK; ETHANOL; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; MIDDLE AGED; PPAR GAMMA; TRANSCRIPTION FACTORS;

EID: 81955167412     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.10.009     Document Type: Article

References (48)

1. A. Tjonneland, Lifestyle Risk Factors for Breast Cancer - Diet, Cancer and Health, a Prospective Cohort Study in Denmark, University of Copenhagen, Copenhagen, 2008.
2. Boffetta P., Hashibe M. Alcohol and cancer. Lancet Oncol. 2006, 7:149-156.
3. Boffetta P., Hashibe M., La V.C., Zatonski W., Rehm J. The burden of cancer attributable to alcohol drinking. Int. J. Cancer 2006, 119:884-887.
4. Sieri S., Agudo A., Kesse E., Klipstein-Grobusch K., San Jose B., Welch A.A., Krogh V., Luben R., Allen N., Overvad K., Tjonneland A., Clavel-Chapelon F., Thiebaut A., Miller A.B., Boeing H., Kolyva M., Saieva C., Celentano E., Ocke M.C., Peeters P.H., Brustad M., Kumle M., Dorronsoro M., Fernandez F.A., Mattisson I., Weinehall L., Riboli E., Slimani N. Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project. Public Health Nutr. 2002, 5:1287-1296.
5. Coutelle C., Hohn B., Benesova M., Oneta C.M., Quattrochi P., Roth H.J., Schmidt-Gayk H., Schneeweiss A., Bastert G., Seitz H.K. Risk factors in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens. Int. J. Oncol. 2004, 25:1127-1132.
6. Rinaldi S., Peeters P.H., Bezemer I.D., Dossus L., Biessy C., Sacerdote C., Berrino F., Panico S., Palli D., Tumino R., Khaw K.T., Bingham S., Allen N.E., Key T., Jensen M.K., Overvad K., Olsen A., Tjonneland A., Amiano P., Ardanaz E., Agudo A., Martinez-Garcia C., Quiros J.R., Tormo M.J., Nagel G., Linseisen J., Boeing H., Schulz M., Grobbee D.E., Bueno-de-Mesquita H.B., Koliva M., Kyriazi G., Thrichopoulou A., Boutron-Ruault M.C., Clavel-Chapelon F., Ferrari P., Slimani N., Saracci R., Riboli E., Kaaks R. Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control 2006, 17:1033-1043.
7. Vogel U., Christensen J., Nexo B.A., Wallin H., Friis S., Tjonneland A. Peroxisome profilerator-activated receptor{gamma}2 Pro12Ala interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis 2007, 28:427-434.
8. Meirhaeghe A., Amouyel P. Impact of genetic variation of PPARgamma in humans. Mol. Genet. Metab. 2004, 83:93-102.
9. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., Laakso M., Fujimoto W., Auwerx J. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity1. Nat. Genet. 1998, 20:284-287.
10. Rubin G.L., Zhao Y., Kalus A.M., Simpson E.R. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Cancer Res. 2000, 60:1604-1608.
11. Beckmann L., Husing A., Setiawan V.W., Amiano P., Clavel-Chapelon F., Chanock S.J., Cox D.G., Diver R., Dossus L., Feigelson H.S., Haiman C., Hallmans G., Hayes R.B., Henderson B.E., Hoover R.N., Hunter D.J., Khaw K., Kolonel L.N., Kraft P., Lund E., Le M.L., Peeters P.H., Riboli E., Stram D., Thomas G., Thun M.J., Tumino R., Trichopoulos D., Vogel U., Willett W.C., Yeager M., Ziegler R., Hankinson S.E., Kaaks R. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J. Clin. Endocrinol. Metab 2011, 96:E360-E367.
12. Chen D., Reierstad S., Lu M., Lin Z., Ishikawa H., Bulun S.E. Regulation of breast cancer-associated aromatase promoters. Cancer Lett. 2009, 273:15-27.
13. Nitz I., Ewert A., Klapper M., Doring F. Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function. Biochem. Biophys. Res. Commun. 2007, 353:481-486.
14. Choi Y.S., Hong J.M., Lim S., Ko K.S., Pak Y.K. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem. Biophys. Res. Commun. 2006, 344:708-712.
15. Tjonneland A., Olsen A., Boll K., Stripp C., Christensen J., Engholm G., Overvad K. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57, 053 men and women in Denmark. Scand. J. Public Health 2007, 35:432-441.
16. Larsen S.B., Vogel U., Christensen J., Hansen R.D., Wallin H., Overvad K., Tjonneland A., Tolstrup J. Interaction between ADH1C Arg(272)Gln and alcohol intake in relation to breast cancer risk suggests that ethanol is the causal factor in alcohol related breast cancer. Cancer Lett. 2010, 295:191-197.
17. Vogel U., Nexo B.A., Olsen A., Thomsen B., Jacobsen N.R., Wallin H., Overvad K., Tjonneland A. No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol. Biomark. Prev 2003, 12:170-171.
18. Nexo B.A., Vogel U., Olsen A., Ketelsen T., Bukowy Z., Thomsen B.L., Wallin H., Overvad K., Tjonneland A. A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of postmenopausal breast cancer at an early age. Carcinogenesis 2003, 24:899-904.
19. Nexo B.A., Vogel U., Olsen A., Nyegaard M., Bukowy Z., Rockenbauer E., Zhang X., Koca C., Mains M., Hansen B., Hedemand A., Kjeldgaard A., Laska M.J., Raaschou-Nielsen O., Cold S., Overvad K., Tjonneland A., Bolund L., Borglum A.D. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP. BMC. Med. Genet. 2008, 9:56.
20. Ravn-Haren G., Olsen A., Tjonneland A., Dragsted L.O., Nexo B.A., Wallin H., Overvad K., Raaschou-Nielsen O., Vogel U. Associations between GPX1 Pro198Leu polymorphism. Erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 2006, 27:820-825.
21. Jacobsen N.R., Nexo B.A., Olsen A., Overvad K., Wallin H., Tjonneland A., Vogel U. No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol. Biomark. Prev. 2003, 12:584-585.
22. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acids Res. 1988, 16:1215.
23. Prentice R.L., Kalbfleisch J.D., Peterson A.V., Flournoy N., Farewell V.T., Breslow N.E. The analysis of failure times in the presence of competing risks. Biometrics 1978, 34:541-554.
24. Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 1995, 6:450-454.
25. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995, 6:356-365.
26. Taxvig C., Vinggaard A.M., Hass U., Axelstad M., Boberg J., Hansen P.R., Frederiksen H., Nellemann C. Do parabens have the ability to interfere with steroidogenesis?. Toxicol. Sci. 2008, 106:206-213.
27. Kliewer S.A., Umesono K., Noonan D.J., Heyman R.A., Evans R.M. Convergence of 9-Cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature 1992, 358:771-774.
28. Tjonneland A., Christensen J., Thomsen B.L., Olsen A., Stripp C., Overvad K., Olsen J.H. Lifetime alcohol consumption and postmenopausal breast cancer rate in Denmark: a prospective cohort study. J. Nutr. 2004, 134:173-178.
29. Friis S., Thomassen L., Sorensen H.T., Tjonneland A., Overvad K., Cronin-Fenton D.P., Vogel U., McLaughlin J.K., Blot W.J., Olsen J.H. Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study. Eur. J. Cancer Prev. 2008, 17:88-96.
30. Tjonneland A., Thomsen B.L., Stripp C., Christensen J., Overvad K., Mellemkaer L., Gronbaek M., Olsen J.H. Alcohol intake drinking patterns and risk of postmenopausal breast cancer in Denmark: a prospective cohort study. Cancer Causes Control 2003, 14:277-284.
31. Tjonneland A., Christensen J., Thomsen B.L., Olsen A., Overvad K., Ewertz M., Mellemkjaer L. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 2004, 100:2328-2337.
32. L. Mellemkjaer, J. Christensen, K. Frederiksen, A. Olsen, P. Bennett, K. Overvad, A. Tjonneland, Associations of body composition measures and endogenous sex-steroid hormones among postmenopausal women. Open Obesity J. in press.
33. Gazdar A.F., Oie H.K., Shackleton C.H., Chen T.R., Triche T.J., Myers C.E., Chrousos G.P., Brennan M.F., Stein C.A., La Rocca R.V. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res. 1990, 50:5488-5496.
34. Boberg J., Metzdorff S., Wortziger R., Axelstad M., Brokken L., Vinggaard A.M., Dalgaard M., Nellemann C. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 2008, 250:75-81.
35. Safi R., Kovacic A., Gaillard S., Murata Y., Simpson E.R., McDonnell D.P., Clyne C.D. Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor gamma coactivator-1alpha on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy. Cancer Res. 2005, 65:11762-11770.
36. Siiteri P.K. Adipose tissue as a source of hormones. Am. J. Clin. Nutr. 1987, 45:277-282.
37. Monteiro R., Soares R., Guerreiro S., Pestana D., Calhau C., Azevedo I. Red wine increases adipose tissue aromatase expression and regulates body weight and adipocyte size. Nutrition 2009, 25:699-705.
38. Memisoglu A., Hankinson S.E., Manson J.E., Colditz G.A., Hunter D.J. Lack of association of the codon 12 polymorphism of the peroxisome proliferator-activated receptor gamma gene with breast cancer and body mass. Pharmacogenetics 2002, 12:597-603.
39. Wang Y., McCullough M.L., Stevens V.L., Rodriguez C., Jacobs E.J., Teras L.R., Pavluck A.L., Thun M.J., Calle E.E. Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer. Anticancer Res. 2007, 27:589-593.
40. Paynter R.A., Hankinson S.E., Colditz G.A., Hunter D.J., De V.I. No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility. Pharmacogenetics 2004, 14:851-856.
41. Calle E.E., Rodriguez C., Jacobs E.J., Almon M.L., Chao A., McCullough M.L., Feigelson H.S., Thun M.J. The American cancer society cancer prevention study II nutrition cohort: rationale, study design, and baseline characteristics. Cancer 2002, 94:2490-2501.
42. 2-mediated c-Abl activation in human hepatic stellate cells. Gastroenterology 2006, 131:1235-1252.
43. Fournier A., Berrino F., Riboli E., Avenel V., Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer. 2005, 114:448-454.
44. La Vecchia C., Gallus S., Fernandez E. Hormone replacement therapy and colorectal cancer: an update. J. Br. Menopause. Soc. 2005, 11:166-172.
45. Vogel U., Christensen J., Dybdahl M., Friis S., Hansen R.D., Wallin H., Nexo B.A., Raaschou-Nielsen O., Andersen P.S., Overvad K., Tjonneland A. Prospective study of interaction between alcohol NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat. Res. 2007, 624:88-100.
46. Chaung W.W., Jacob A., Ji Y., Wang P. Suppression of PGC-1alpha by ethanol: implications of its role in alcohol induced liver injury. Int. J. Clin. Exp. Med. 2008, 1:161-170.
47. Heikkinen S., Auwerx J., Argmann C.A. PPARgamma in human and mouse physiology. Biochim. Biophys. Acta 2007, 1771:999-1013.
48. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre. Toxicol. 2006, 3(11):11.